Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Objectives: To evaluate potential return on investment of the National Health Service Diabetes Prevention Programme (NHS DPP) in England and estimate which population subgroups are likely to benefit most in terms of cost-effectiveness, cost-savings and health benefits. Design: Economic analysis using the School for Public Health Research Diabetes Prevention Model. Setting: England 2015–2016. Population: Adults aged ≥16 with high risk of type 2 diabetes (HbA1c 6%–6.4%). Population subgroups defined by age, sex, ethnicity, socioeconomic deprivation, baseline body mass index, baseline HbA1c and working status. Interventions: The proposed NHS DPP: an intensive lifestyle intervention focusing on dietary advice, physical activity and weight loss. Comparator: no diabetes prevention intervention. Main outcome measures: Incremental costs, savings and return on investment, quality-adjusted life-years (QALYs), diabetes cases, cardiovascular cases and net monetary benefit from an NHS perspective. Results: Intervention costs will be recouped through NHS savings within 12 years, with net NHS saving of £1.28 over 20 years for each £1 invested. Per 100 000 DPP interventions given, 3552 QALYs are gained. The DPP is most cost-effective and cost-saving in obese individuals, those with baseline HbA1c 6.2%–6.4% and those aged 40–74. QALY gains are lower in minority ethnic and low socioeconomic status subgroups. Probabilistic sensitivity analysis suggests that there is 97% probability that the DPP will be cost-effective within 20 years. NHS savings are highly sensitive to intervention cost, effectiveness and duration of effect. Conclusions: The DPP is likely to be cost-effective and cost-saving under current assumptions. Prioritising obese individuals could create the most value for money and obtain the greatest health benefits per individual targeted. Low socioeconomic status or ethnic minority groups may gain fewer QALYs per intervention, so targeting strategies should ensure the DPP does not contribute to widening health inequalities. Further evidence is needed around the differential responsiveness of population subgroups to the DPP.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“associated with intensive lifestyle intervention compared with control, these are not significant so were not incorporated into the analysis.(11) There is some evidence to indicate that effectiveness of lifestyle interventions to prevent type 2 diabetes differs between population subgroups, although study quality vari…”
BackgroundPredicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
Hippisley-Cox, J., Coupland, C., Vinogradova, Y., Robson, J., Minhas, R., Sheikh, A., & Brindle, P. (2008) · BMJ · doi:10.1136/bmj.39609.449676.25 · Cited by 1,459 · cited 1×
“First, disease risk is influenced by subgroup; for example, both ethnicity and socioeconomic status are parameters in the QRISK equations that are used in the model to determine CVD risk.(22) This means that even if a given individual reduces their metabolic risk factors through the DPP they may still be at high risk…”
MethodGillies, C. L., Abrams, K. R., Lambert, P. C., Cooper, N. J., Sutton, A. J., Hsu, R. T., & Khunti, K. (2007) · BMJ · doi:10.1136/bmj.39063.689375.55 · Cited by 1,171
Dunkley, A. J., Bodicoat, D. H., Greaves, C. J., Russell, C., Yates, T., Davies, M. J., & Khunti, K. (2014) · Diabetes Care · doi:10.2337/dc13-2195 · Cited by 542
Gupta, J. K., Daniels, J. P., Middleton, L. J., Pattison, H. M., Prileszky, G., Roberts, T. E., Sanghera, S., Barton, P., Gray, R., Kai, J., et al. (2015) · Health Technology Assessment · doi:10.3310/hta19880 · Cited by 399
The Diabetes Prevention Program Research Group [Prepared by Jill Crandall, D. S. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.10.1075 · Cited by 254
Cited by
Early Outcomes From the English National Health Service Diabetes Prevention Programme
Valabhji, J., Barron, E., Bradley, D., Bakhai, C., Fagg, J., O’Neill, S., Young, B., Wareham, N., Khunti, K., Jebb, S., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1425 · Cited by 211
“The rationale, justification, development, and early implementation of the programhave beendescribed previously (10), and an impact analysis has demonstrated the potential for realizing return on investment within 12 years (11).”
BackgroundGruss, S. M., Nhim, K., Gregg, E., Bell, M., Luman, E., & Albright, A. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1200-z · Cited by 179
Opie, R. S., Jacka, F. N., Marx, W., Rocks, T., Young, C., & O’Neil, A. (2021) · Nutrients · doi:10.3390/nu13113766 · Cited by 16
McManus, E. (2024) · PharmacoEconomics - Open · doi:10.1007/s41669-024-00487-6 · Cited by 10
Frempong, S. N., Shinkins, B., Howdon, D., Messenger, M., Neal, R. D., & Sagoo, G. S. (2022) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2021.1895755 · Cited by 5
Metadata
- Authors
- Thomas, C., Sadler, S., Breeze, P., Squires, H., Gillett, M., & Brennan, A.
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2017-08
- Volume
- 7
- Issue
- 8
- Pages
- e014953
- ISSN
- 2044-6055 (ISSN-L)
- OpenAlex
- W2724842640
- Cited by
- 42
- References
- 6
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation. https://app.cochat.ai/papers/10.1136/bmjopen-2016-014953
- The paper
- Thomas, C., Sadler, S., Breeze, P., Squires, H., Gillett, M., & Brennan, A. (2017). Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation. BMJ Open. https://doi.org/10.1136/bmjopen-2016-014953
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.